Gain Therapeutics Inc (GANX) Insider Trading
- $218,327.56
- $506.76
- Aug. 9, 2024
- Eric I Richman
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 9, 2024 | CEO | 14,400 | $1.01 | Buy | $14,544.00 | |
| Aug. 9, 2024 | Chairman | 50,000 | $1.00 | Buy | $50,000.00 | |
| July 1, 2024 | Director | 17,000 | $1.22 | Buy | $20,740.00 | |
| March 28, 2024 | Director | 30,000 | $3.86 | Buy | $115,800.00 | |
| Dec. 21, 2023 | CEO | 206 | $2.46 | Sell | $506.76 | |
| May 25, 2022 | CEO | 2,482 | $2.58 | Buy | $6,403.56 | |
| May 19, 2022 | CEO | 4,000 | $2.71 | Buy | $10,840.00 |
Insiders are both buying and selling Gain Therapeutics Inc stock.
The insider traders at Gain Therapeutics Inc are: Eric I Richman, Gene Mack, Jeffrey Scott Riley, Khalid Islam, and Matthias Alder
The most active insider trader at Gain Therapeutics Inc is Eric I Richman with 3 trades.
Matthias Alder has sold the most Gain Therapeutics Inc stock with a total value of $1,013.52.
Jeffrey Scott Riley has bought the most Gain Therapeutics Inc stock with a total value of $231,600.00.
The most recent insider trade for Gain Therapeutics Inc was on Aug. 9, 2024.
The single biggest insider buy for Gain Therapeutics Inc was from Jeffrey Scott Riley with a total value of $115,800.00 on March 28, 2024.
The single biggest insider sell for Gain Therapeutics Inc was from Matthias Alder with a total value of $506.76 on Dec. 21, 2023.